Reclazepam
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H13Cl2N3O2 |
Molar mass | 374.22 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
| |
Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]
See also[]
- Benzodiazepine
References[]
- ^ US Patent 4208327
- ^ Pscyhotropics.dk (20 January 1986). "reclazepam". Retrieved 24 August 2009.
Benzodiazepines | |
---|---|
1,4-Benzodiazepines |
|
1,5-Benzodiazepines |
|
2,3-Benzodiazepines* |
|
Triazolobenzodiazepines |
|
Imidazobenzodiazepines |
|
Oxazolobenzodiazepines |
|
Thienodiazepines | |
Thienotriazolodiazepines |
|
Thienobenzodiazepines* | |
Pyridodiazepines |
|
Pyridotriazolodiazepines |
|
Pyrazolodiazepines | |
Pyrrolodiazepines | |
Tetrahydroisoquinobenzodiazepines | |
Pyrrolobenzodiazepines* |
|
Benzodiazepine prodrugs |
|
* atypical activity profile (not GABAA receptor ligands) |
GABAA receptor positive modulators | |
---|---|
Alcohols |
|
Barbiturates |
|
Benzodiazepines |
|
Carbamates |
|
Flavonoids |
|
Imidazoles |
|
Kava constituents |
|
Monoureides |
|
Neuroactive steroids |
|
Nonbenzodiazepines |
|
Phenols |
|
Piperidinediones |
|
Pyrazolopyridines |
|
Quinazolinones |
|
Volatiles/gases |
|
Others/unsorted |
|
See also: Receptor/signaling modulators • GABA receptor modulators • GABA metabolism/transport modulators |
This sedative-related article is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Benzodiazepines
- Chloroarenes
- GABAA receptor positive allosteric modulators
- Oxazolones
- Sedative stubs
Hidden categories:
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- All stub articles